CellaVision AB (publ) (LON:0MR5)

CellaVision AB Statistics

Total Valuation

CellaVision AB has a market cap or net worth of GBP 299.04 million. The enterprise value is 288.46 million.

Market Cap	299.04M
Enterprise Value	288.46M

Important Dates

The next estimated earnings date is Thursday, February 5, 2026.

Earnings Date	Feb 5, 2026
Ex-Dividend Date	May 7, 2025

Share Statistics

Current Share Class	23.85M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.89%
Owned by Institutions (%)	61.38%
Float	19.82M

Valuation Ratios

The trailing PE ratio is 25.02 and the forward PE ratio is 21.28.

PE Ratio	25.02
Forward PE	21.28
PS Ratio	5.06
PB Ratio	4.45
P/TBV Ratio	5.88
P/FCF Ratio	21.72
P/OCF Ratio	19.41
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.62, with an EV/FCF ratio of 20.95.

EV / Earnings	24.13
EV / Sales	4.79
EV / EBITDA	15.62
EV / EBIT	18.08
EV / FCF	20.95

Financial Position

The company has a current ratio of 3.31, with a Debt / Equity ratio of 0.03.

Current Ratio	3.31
Quick Ratio	2.43
Debt / Equity	0.03
Debt / EBITDA	0.12
Debt / FCF	0.16
Interest Coverage	31.85

Financial Efficiency

Return on equity (ROE) is 18.70% and return on invested capital (ROIC) is 14.74%.

Return on Equity (ROE)	18.70%
Return on Assets (ROA)	12.03%
Return on Invested Capital (ROIC)	14.74%
Return on Capital Employed (ROCE)	20.93%
Revenue Per Employee	255,806
Profits Per Employee	51,747
Employee Count	219
Asset Turnover	0.73
Inventory Turnover	2.03

Taxes

In the past 12 months, CellaVision AB has paid 3.14 million in taxes.

Income Tax	3.14M
Effective Tax Rate	20.82%

Stock Price Statistics

The stock price has decreased by -31.97% in the last 52 weeks. The beta is 1.36, so CellaVision AB's price volatility has been higher than the market average.

Beta (5Y)	1.36
52-Week Price Change	-31.97%
50-Day Moving Average	167.37
200-Day Moving Average	174.78
Relative Strength Index (RSI)	36.60
Average Volume (20 Days)	547

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellaVision AB had revenue of GBP 59.09 million and earned 11.95 million in profits. Earnings per share was 0.50.

Revenue	59.09M
Gross Profit	40.84M
Operating Income	15.66M
Pretax Income	15.10M
Net Income	11.95M
EBITDA	17.17M
EBIT	15.66M
Earnings Per Share (EPS)	0.50

Balance Sheet

The company has 12.53 million in cash and 2.15 million in debt, giving a net cash position of 10.37 million.

Cash & Cash Equivalents	12.53M
Total Debt	2.15M
Net Cash	10.37M
Net Cash Per Share	n/a
Equity (Book Value)	67.23M
Book Value Per Share	2.82
Working Capital	23.45M

Cash Flow

In the last 12 months, operating cash flow was 15.40 million and capital expenditures -1.64 million, giving a free cash flow of 13.77 million.

Operating Cash Flow	15.40M
Capital Expenditures	-1.64M
Free Cash Flow	13.77M
FCF Per Share	n/a

Margins

Gross margin is 69.11%, with operating and profit margins of 26.50% and 20.23%.

Gross Margin	69.11%
Operating Margin	26.50%
Pretax Margin	25.55%
Profit Margin	20.23%
EBITDA Margin	29.06%
EBIT Margin	26.50%
FCF Margin	23.30%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.13%.

Dividend Per Share	0.20
Dividend Yield	0.13%
Dividend Growth (YoY)	17.77%
Years of Dividend Growth	n/a
Payout Ratio	39.38%
Buyback Yield	n/a
Shareholder Yield	0.13%
Earnings Yield	4.00%
FCF Yield	4.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7